SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-20-014192
Filing Date
2020-07-29
Accepted
2020-07-29 17:14:23
Documents
10
Period of Report
2020-07-23
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 37999
2 ex10-1.htm EX-10.1 146913
3 ex10-2.htm EX-10.2 63178
4 ex10-2_01.jpg GRAPHIC 10641
5 ex10-3.htm EX-10.3 101760
6 ex10-4.htm EX-10.4 105275
7 ex10-5.htm EX-10.5 114867
8 ex10-6.htm EX-10.6 133651
9 ex99-1.htm EX-99.1 20068
10 image_002.jpg GRAPHIC 635
  Complete submission text file 0001493152-20-014192.txt   740779
Mailing Address 29397 AGOURA RD. #107 AGUORA HILLS CA 91301
Business Address 29397 AGOURA RD. #107 AGUORA HILLS CA 91301 650-635-7000
MATEON THERAPEUTICS INC (Filer) CIK: 0000908259 (see all company filings)

IRS No.: 133679168 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-21990 | Film No.: 201057937
SIC: 2834 Pharmaceutical Preparations